Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $8.17 Million - $9.86 Million
30,383 New
30,383 $8.64 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $96.7 Million - $123 Million
-422,371 Reduced 86.66%
65,037 $17.1 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $12.2 Million - $13.8 Million
54,546 Added 12.6%
487,408 $110 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $99.9 Million - $111 Million
432,862 New
432,862 $105 Million
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $7.71 Million - $8.53 Million
-35,177 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $60.4 Million - $69.1 Million
-303,584 Reduced 89.62%
35,177 $7.91 Million
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $64.6 Million - $75.7 Million
304,182 Added 879.67%
338,761 $72 Million
Q2 2021

Aug 16, 2021

BUY
$233.58 - $259.14 $8.08 Million - $8.96 Million
34,579 New
34,579 $8.43 Million
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $55.7 Million - $64.9 Million
-251,139 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $54.3 Million - $64.7 Million
251,139 New
251,139 $57.7 Million
Q3 2020

Nov 16, 2020

SELL
$234.65 - $260.95 $1.7 Million - $1.89 Million
-7,235 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $1.1 Million - $1.35 Million
5,553 Added 330.14%
7,235 $1.71 Million
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $6.93 Million - $9.2 Million
-38,046 Reduced 95.77%
1,682 $341,000
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $1.77 Million - $2.28 Million
-9,365 Reduced 19.08%
39,728 $9.58 Million
Q3 2019

Nov 14, 2019

BUY
$174.11 - $208.62 $5.89 Million - $7.06 Million
33,839 Added 221.84%
49,093 $9.5 Million
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $23 Million - $27 Million
-138,118 Reduced 90.05%
15,254 $2.81 Million
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $27.7 Million - $31.3 Million
153,372 New
153,372 $29.1 Million
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $14.8 Million - $17.3 Million
-83,131 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $15.4 Million - $17.4 Million
83,131 New
83,131 $17.2 Million
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $10 Million - $11.7 Million
-59,159 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $9.99 Million - $11.2 Million
59,159
59,159 $10.3 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.